ADAGIO MEDICAL HOLDINGS INC (ADGM) Stock Price & Overview

NASDAQ:ADGM • US00534B1008

Current stock price

1.03 USD
+0.13 (+14.41%)
At close:
1.0148 USD
-0.02 (-1.48%)
After Hours:

The current stock price of ADGM is 1.03 USD. Today ADGM is up by 14.41%. In the past month the price decreased by -17.6%. In the past year, price decreased by -18.25%.

ADGM Key Statistics

52-Week Range0.74 - 2.582
Current ADGM stock price positioned within its 52-week range.
1-Month Range0.8513 - 1.69
Current ADGM stock price positioned within its 1-month range.
Market Cap
22.876M
P/E
N/A
Fwd P/E
N/A
EPS (TTM)
-1.58
Dividend Yield
N/A

ADGM Stock Performance

Today
+14.41%
1 Week
-31.79%
1 Month
-17.60%
3 Months
+3.00%
Longer-term
6 Months -9.65%
1 Year -18.25%
2 Years N/A
3 Years N/A
5 Years N/A
10 Years N/A

ADGM Stock Chart

ADAGIO MEDICAL HOLDINGS INC / ADGM Daily stock chart

ADGM Technical Analysis

ChartMill assigns a technical rating of 2 / 10 to ADGM. When comparing the yearly performance of all stocks, ADGM is a bad performer in the overall market: 78.58% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

ADGM Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to ADGM. Both the profitability and financial health of ADGM have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

ADGM Earnings

Next Earnings DateMay 14, 2026
Last Earnings DateMar 27, 2026
PeriodQ4 / 2025
EPS Reported-$0.16
Revenue Reported
EPS Surprise 49.40%
Revenue Surprise %

ADGM Forecast & Estimates

7 analysts have analysed ADGM and the average price target is 3.57 USD. This implies a price increase of 246.6% is expected in the next year compared to the current price of 1.03.


Analysts
Analysts82.86
Price Target3.57 (246.6%)
EPS Next Y43.11%
Revenue Next YearN/A

ADGM Financial Highlights

Over the last trailing twelve months ADGM reported a non-GAAP Earnings per Share(EPS) of -1.58. The EPS increased by 65.93% compared to the year before.


Income Statements
Revenue(TTM)N/A
Net Income(TTM)-25.08M
Industry RankSector Rank
PM (TTM) N/A
ROA -57.99%
ROE -202.26%
Debt/Equity 1.7
Chartmill High Growth Momentum
EPS Q2Q%95.09%
Sales Q2Q%-100%
EPS 1Y (TTM)65.93%
Revenue 1Y (TTM)-100%

ADGM Ownership

Ownership
Inst Owners30.93%
Shares22.21M
Float11.58M
Ins Owners3.31%
Short Float %0.44%
Short Ratio0.43

ADGM Industry Overview

ADGM operates in the Health Care Equipment sub-industry within the Health Care sector. This group contains 127 stocks and is scored by ChartMill on both price strength and growth momentum.

Industry Strength Score

11/100
Composite price performance score based on 3, 6, and 12-month returns, with more weight on recent trends.

Industry Growth Score

59/100
Composite growth score based on earnings growth, revenue growth, and profitability across the sub-industry.

Relative Performance

Each rank shows how many other sub-industries were outperformed over that timeframe.

1 Month Rank
22%
Outperformed 22% of sub-industries
3 Month Rank
14%
Outperformed 14% of sub-industries
6 Month Rank
11%
Outperformed 11% of sub-industries

Industry Fundamentals & Breadth

Members
127
New Highs
2.4%
New Lows
14.2%
Average ROE
17.2%
Average Profit Margin
20.3%
Average Operating Margin
22.5%
Average P/E
28.3
Average Fwd P/E
27.4
Average Debt/Equity
0.5

About ADGM

Company Profile

ADGM logo image Adagio Medical Holdings, Inc. is a medical device company, which engages in the development ablation technologies for the treatment of cardiac arrhythmias. The company is headquartered in Laguna Hills, California and currently employs 86 full-time employees. The company went IPO on 2021-02-26. The company is focused on developing proprietary Ultra-Low Temperature Cryoablation technology that creates contiguous, transmural lesions to treat cardiac arrhythmias, with an emphasis on ventricular tachycardia. The company is developing and placing on the European Union (EU) market ablation technologies for the treatment of cardiac arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia. Its product portfolio consists of three product families: iCLAS atrial ULTC catheter and accessories, vCLAS ventricular ULTC catheter, and Cryopulse atrial PFCA catheter and accessories. All of these catheters share the same ULTC cryoablation console. The iCLAS system is CE-marked with the indication for treatment of paroxysmal atrial fibrillation, persistent atrial fibrillation and atrial flutter. The vCLAS ventricular catheter has been specifically designed for the treatment of ventricular arrhythmia.

Company Info

IPO: 2021-02-26

ADAGIO MEDICAL HOLDINGS INC

26051 Merit Circle, Suite 102

Laguna Hills CALIFORNIA US

Employees: 80

ADGM Company Website

Phone: 19493481188

ADAGIO MEDICAL HOLDINGS INC / ADGM FAQ

What does ADAGIO MEDICAL HOLDINGS INC do?

Adagio Medical Holdings, Inc. is a medical device company, which engages in the development ablation technologies for the treatment of cardiac arrhythmias. The company is headquartered in Laguna Hills, California and currently employs 86 full-time employees. The company went IPO on 2021-02-26. The company is focused on developing proprietary Ultra-Low Temperature Cryoablation technology that creates contiguous, transmural lesions to treat cardiac arrhythmias, with an emphasis on ventricular tachycardia. The company is developing and placing on the European Union (EU) market ablation technologies for the treatment of cardiac arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia. Its product portfolio consists of three product families: iCLAS atrial ULTC catheter and accessories, vCLAS ventricular ULTC catheter, and Cryopulse atrial PFCA catheter and accessories. All of these catheters share the same ULTC cryoablation console. The iCLAS system is CE-marked with the indication for treatment of paroxysmal atrial fibrillation, persistent atrial fibrillation and atrial flutter. The vCLAS ventricular catheter has been specifically designed for the treatment of ventricular arrhythmia.


Can you provide the latest stock price for ADAGIO MEDICAL HOLDINGS INC?

The current stock price of ADGM is 1.03 USD. The price increased by 14.41% in the last trading session.


Does ADAGIO MEDICAL HOLDINGS INC pay dividends?

ADGM does not pay a dividend.


How is the ChartMill rating for ADAGIO MEDICAL HOLDINGS INC?

ADGM has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 1 out of 10.


Can you provide the upcoming earnings date for ADAGIO MEDICAL HOLDINGS INC?

ADAGIO MEDICAL HOLDINGS INC (ADGM) will report earnings on 2026-05-14.


Can you provide the short interest for ADGM stock?

The outstanding short interest for ADAGIO MEDICAL HOLDINGS INC (ADGM) is 0.44% of its float.